Cargando…

Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) Patients

Mutations identified in the epidermal growth factor receptor (EGFR) predict sensitivity to EGFR-targeted therapy for non-small cell lung carcinoma (NSCLC). We previously reported that Electric Field-Induced Release and Measurement (EFIRM)-based liquid biopsy could detect EGFR ctDNA with >94% conc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Feng, Wei, Fang, Huang, Wei-Lun, Lin, Chien-Chung, Li, Liang, Shen, Macy M., Yan, Qingxiang, Liao, Wei, Chia, David, Tu, Michael, Tang, Jason H., Feng, Ziding, Kim, Yong, Su, Wu-Chou, Wong, David T. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464208/ https://www.ncbi.nlm.nih.gov/pubmed/32722209 http://dx.doi.org/10.3390/cancers12082041

Ejemplares similares

Zone-Shrinking Fresnel Zone Travel-Time Tomography for Sound Speed Reconstruction in Breast USCT
por: Fang, Xiaoyue, et al.
Publicado: (2020)

The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer
por: Huang, Wei-Lun, et al.
Publicado: (2015)

Real‐world outcomes of NSCLC patients receiving tissue or circulating tumor DNA‐guided osimertinib treatment
por: Su, Po‐Lan, et al.
Publicado: (2019)

Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma
por: Kim, Chul, et al.
Publicado: (2021)

DNA terminal structure-mediated enzymatic reaction for ultra-sensitive discrimination of single nucleotide variations in circulating cell-free DNA
por: Wu, Tongbo, et al.
Publicado: (2018)

Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC
por: Wu, Jun, et al.
Publicado: (2022)

Evaluating Pre-Analytical Variables for Saliva Cell-Free DNA Liquid Biopsy
por: Salfer, Blake, et al.
Publicado: (2023)

Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC
por: MacManus, Michael, et al.
Publicado: (2023)

Bartonella DNA in Dog Saliva
por: Duncan, Ashlee W., et al.
Publicado: (2007)

Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients
por: Catarino, Raquel, et al.
Publicado: (2012)

Rescue of Non-Informative Circulating Tumor DNA to Monitor the Mutational Landscape in NSCLC
por: Mayer, Stefanie, et al.
Publicado: (2020)

Circulating Cell-Free DNA-Based Methylation Pattern in Saliva for Early Diagnosis of Head and Neck Cancer
por: Birknerova, Natalia, et al.
Publicado: (2022)

Prognostic Value of Circulating Tumor DNA (ctDNA) in Oncogene-Driven NSCLC: Current Knowledge and Future Perspectives
por: Zografos, Eleni, et al.
Publicado: (2022)

Longitudinal Monitoring of EGFR and PIK3CA Mutations by Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports
por: Li, Ning, et al.
Publicado: (2020)

EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience
por: Ianza, Anna, et al.
Publicado: (2021)

Evaluation of a novel saliva‐based epidermal growth factor receptor mutation detection for lung cancer: A pilot study
por: Pu, Dan, et al.
Publicado: (2016)

The clinical characteristics and prognostic analysis of Chinese advanced NSCLC patients based on circulating tumor DNA sequencing
por: Rao, Chuangzhou, et al.
Publicado: (2018)

Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNA
por: Cheng, Jordan, et al.
Publicado: (2022)

Comparison of the SuperARMS and Droplet Digital PCR for Detecting EGFR Mutation in ctDNA From NSCLC Patients
por: Feng, Wei-neng, et al.
Publicado: (2018)

Saliva Liquid Biopsy for Point-of-Care Applications
por: Aro, Katri, et al.
Publicado: (2017)

Birthweight DNA methylation signatures in infant saliva
por: Moccia, Chiara, et al.
Publicado: (2021)

Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis
por: Luo, Jie, et al.
Publicado: (2014)

Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs
por: Zhang, Chengjuan, et al.
Publicado: (2017)

Detection and Significance of Cell-Free DNA Mutation in Pleural Effusion in Patients with Advanced NSCLC
por: Qiao, Man, et al.
Publicado: (2022)

Single-Droplet Microsensor for Ultra-Short Circulating EFGR Mutation Detection in Lung Cancer Based on Multiplex EFIRM Liquid Biopsy
por: Wei, Fang, et al.
Publicado: (2023)

Quality of DNA extracted from saliva samples collected with the Oragene™ DNA self-collection kit
por: Nunes, Ana P, et al.
Publicado: (2012)

Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer
por: Cao, Feng, et al.
Publicado: (2020)

Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice
por: Cho, Byoung Chul, et al.
Publicado: (2022)

Clinical trial participant characteristics and saliva and DNA metrics
por: Nishita, Denise M, et al.
Publicado: (2009)

Comparing DNA methylation profiles in saliva and intestinal mucosa
por: Hearn, Nerissa L., et al.
Publicado: (2019)

DNA Methylation Studies in Saliva of Patients with Sjögren’s Syndrome
por: Karagianni, Panagiota, et al.
Publicado: (2021)

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
por: Krug, A K, et al.
Publicado: (2018)

Circulating Tumor DNA correlates with Lactate Dehydrogenase, CYFRA 21-1, and CRP levels in patients with advanced NSCLC
por: Buresova, Marcela, et al.
Publicado: (2023)

Saliva DNA quality and genotyping efficiency in a predominantly elderly population
por: Gudiseva, Harini V., et al.
Publicado: (2016)

Suppressing high-dimensional crystallographic defects for ultra-scaled DNA arrays
por: Chen, Yahong, et al.
Publicado: (2022)

Ultra-Low DNA Input into Whole Genome Methylation Assays and Detection of Oncogenic Methylation and Copy Number Variants in Circulating Tumour DNA
por: Whalley, Celina, et al.
Publicado: (2021)

Circulating tumor DNA in hepatocellular carcinoma: trends and challenges
por: Tang, Jia-Cheng, et al.
Publicado: (2016)

DNA nano-pocket for ultra-selective uranyl extraction from seawater
por: Yuan, Yihui, et al.
Publicado: (2020)

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
por: Douillard, Jean-Yves, et al.
Publicado: (2014)

Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study
por: Lamy, Pierre-Jean, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5gkj2phfe4ucb8s0s8ght0196e